✦ LIBER ✦

Rivaroxaban versus warfarin in Japanese patients with non-valvular atrial fibrillation in relation to hypertension: a subgroup analysis of the J-ROCKET AF trial

✍ Scribed by Matsumoto, Masayasu; Hori, Masatsugu; Tanahashi, Norio; Momomura, Shin-ichi; Uchiyama, Shinichiro; Goto, Shinya; Izumi, Tohru; Koretsune, Yukihiro; Kajikawa, Mariko; Kato, Masaharu; Ueda, Hitoshi; Iekushi, Kazuma; Yamanaka, Satoshi; Tajiri, Masahiro

Book ID: 125535812
Publisher: Nature Publishing Group
Year: 2014
Tongue: English
Weight: 302 KB
Volume: 37
Category: Article
ISSN: 0916-9636
DOI: 10.1038/hr.2014.1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rivaroxaban versus Warfarin in Japanese

Rivaroxaban versus Warfarin in Japanese Patients with Nonvalvular Atrial Fibrillation in Relation to the CHADS2 Score: A Subgroup Analysis of the J-ROCKET AF Trial

✍ Hori, Masatsugu; Matsumoto, Masayasu; Tanahashi, Norio; Momomura, Shin-ichi; Uch 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 245 KB

Net Clinical Benefit of Rivaroxaban vers

Net Clinical Benefit of Rivaroxaban versus Warfarin in Japanese Patients with Nonvalvular Atrial Fibrillation: A Subgroup Analysis of J-ROCKET AF

✍ Uchiyama, Shinichiro; Hori, Masatsugu; Matsumoto, Masayasu; Tanahashi, Norio; Mo 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 403 KB

OUTCOMES OF PATIENTS WITH ATRIAL FIBRILL

OUTCOMES OF PATIENTS WITH ATRIAL FIBRILLATION AND SIGNIFICANT VALVULAR LESIONS: COMPARISON OF THE EFFECTS OF RIVAROXABAN AND WARFARIN IN THE ROCKET AF TRIAL

✍ Breithardt, Guenter; Berkowitz, Scott; Baumgartner, Helmut; Hellkamp, Anne; Picc 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Rivaroxaban compared with warfarin in pa

Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF

✍ Graeme J Hankey; Manesh R Patel; Susanna R Stevens; Richard C Becker; Günter Bre 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 252 KB

Efficacy and safety of rivaroxaban compa

Efficacy and safety of rivaroxaban compared with warfarin in patients with peripheral artery disease and non-valvular atrial fibrillation: insights from ROCKET AF

✍ Jones, W. S.; Hellkamp, A. S.; Halperin, J.; Piccini, J. P.; Breithardt, G.; Sin 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 290 KB

Warfarin for the prevention of systemic

Warfarin for the prevention of systemic embolism in patients with non-valvular atrial fibrillation: a meta-analysis

✍ Andersen, L V; Vestergaard, P; Deichgraeber, P; Lindholt, J S; Mortensen, L S; F 📂 Article 📅 2008 🏛 BMJ 🌐 English ⚖ 435 KB